Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribavirin versus colchicine monotherapy for advanced fibrosis in chronic hepatitis C
2007-007096-16Phase 2Active
- Sponsor
- AgustÃn Albillos Martinez
- Start
- Jan 2008
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in hepatitis C virus infection comparing Ribavirin monotherapy with Colchicine monotherapy (2 arms). Primary endpoint: Progression of liver disease. Started Jan 2008; status: active.
02
Drugs
ribavirincolchicine
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2007-007096-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007096-16.